title: [Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives].
authors.affiliation: INSERM U24, Hôpital Beaujon, Clichy.
authors.forename: P
authors.initials: P
authors.lastname: Marcellin
authors.forename: M
authors.initials: M
authors.lastname: Pouteau
authors.forename: M
authors.initials: M
authors.lastname: Martinot
authors.forename: N
authors.initials: N
authors.lastname: Boyer
authors.forename: C
authors.initials: C
authors.lastname: Castelnau
authors.forename: J P
authors.initials: JP
authors.lastname: Benhamou
authors.forename: S
authors.initials: S
authors.lastname: Erlinger
mesh_terms: D000367:Age Factors; D000998:Antiviral Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006526:Hepatitis C / Q000628:therapy* / Q000821:virology; D006521:Hepatitis, Chronic / Q000628:therapy* / Q000821:virology; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects; D008297:Male; D012008:Recurrence; D012254:Ribavirin / Q000627:therapeutic use; D012737:Sex Factors
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin
vernacular_title: Facteurs de réponse au traitement par l'interféron alpha chez les malades atteints d'hépatite chronique C. Perspectives thérapeutiques.